Rheumatoid Arthritis:,XELJANZ is indicated for the treatment of moderate to severe active rheumatoid arthritis in
adults who have had an inadequate response or are intolerant to methotrexate. XELJANZ
can be used alone or in combination with conventional synthetic disease-modifying
antirheumatic drugs (DMARDs), including methotrexate.,Psoriatic Arthritis: XELJANZ in combination with conventional synthetic DMARDs is indicated for the
treatment of active psoriatic arthritis in adult patients who have had an inadequate response to
a prior DMARD therapy.,Ulcerative Colitis: XELJANZ is indicated for the treatment of adult patients with moderately to severely active ulcerative colitis (UC) who have had an inadequate response, lost response, or were intolerant to either conventional therapy or a biological therapy.,Psoriatic Arthritis:
XELJANZ in combination with conventional synthetic DMARDs is indicated for the
treatment of active psoriatic arthritis in adult patients who have had an inadequate response to
a prior DMARD therapy.,Ulcerative Colitis
XELJANZ is indicated for the treatment of adult patients with moderately to severely active
ulcerative colitis (UC) who have had an inadequate response, lost response, or were intolerant
to either conventional therapy or a biological therapy.
How to take it
The way to take this medicine is: Oral.
This medicine is taken by mouth.
Store below 30 degrees Celsius
Shelf lifetime is 3 Years.
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.
Always read the label. If symptoms persist see your healthcare professional.
Visual appearance
White, round, film-coated tablet debossed with 'Pfizer' on one side and 'JKI 5' on the other side.
Do I need a prescription?
This medicine is available from a pharmacist and requires a prescription. It is
Schedule 4 : Prescription Only Medicine.
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
This medicine is under additional monitoring as it is new or being used in a different way. You can help identify new safety information by reporting any side effects you may get.
Rheumatoid Arthritis:,XELJANZ is indicated for the treatment of moderate to severe active rheumatoid arthritis in
adults who have had an inadequate response or are intolerant to methotrexate. XELJANZ
can be used alone or in combination with conventional synthetic disease-modifying
antirheumatic drugs (DMARDs), including methotrexate.,Psoriatic Arthritis: XELJANZ in combination with conventional synthetic DMARDs is indicated for the
treatment of active psoriatic arthritis in adult patients who have had an inadequate response to
a prior DMARD therapy.,Ulcerative Colitis: XELJANZ is indicated for the treatment of adult patients with moderately to severely active ulcerative colitis (UC) who have had an inadequate response, lost response, or were intolerant to either conventional therapy or a biological therapy.,Psoriatic Arthritis:
XELJANZ in combination with conventional synthetic DMARDs is indicated for the
treatment of active psoriatic arthritis in adult patients who have had an inadequate response to
a prior DMARD therapy.,Ulcerative Colitis
XELJANZ is indicated for the treatment of adult patients with moderately to severely active
ulcerative colitis (UC) who have had an inadequate response, lost response, or were intolerant
to either conventional therapy or a biological therapy.
How to take it
The way to take this medicine is: Oral.
This medicine is taken by mouth.
Store below 30 degrees Celsius
Shelf lifetime is 3 Years.
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.
Always read the label. If symptoms persist see your healthcare professional.
Visual appearance
White, round, film-coated tablet debossed with 'Pfizer' on one side and 'JKI 5' on the other side.
Do I need a prescription?
This medicine is available from a pharmacist and requires a prescription. It is
Schedule 4 : Prescription Only Medicine.
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
This medicine is under additional monitoring as it is new or being used in a different way. You can help identify new safety information by reporting any side effects you may get.
Rheumatoid Arthritis:,XELJANZ is indicated for the treatment of moderate to severe active rheumatoid arthritis in
adults who have had an inadequate response or are intolerant to methotrexate. XELJANZ
can be used alone or in combination with conventional synthetic disease-modifying
antirheumatic drugs (DMARDs), including methotrexate.,Psoriatic Arthritis: XELJANZ in combination with conventional synthetic DMARDs is indicated for the
treatment of active psoriatic arthritis in adult patients who have had an inadequate response to
a prior DMARD therapy.,Ulcerative Colitis: XELJANZ is indicated for the treatment of adult patients with moderately to severely active ulcerative colitis (UC) who have had an inadequate response, lost response, or were intolerant to either conventional therapy or a biological therapy.,Psoriatic Arthritis:
XELJANZ in combination with conventional synthetic DMARDs is indicated for the
treatment of active psoriatic arthritis in adult patients who have had an inadequate response to
a prior DMARD therapy.,Ulcerative Colitis:
XELJANZ is indicated for the treatment of adult patients with moderately to severely active ulcerative colitis (UC) who have had an inadequate response, lost response, or were intolerant to either conventional therapy or a biological therapy.
How to take it
The way to take this medicine is: Oral.
This medicine is taken by mouth.
Store below 30 degrees Celsius
Shelf lifetime is 3 Years.
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.
Always read the label. If symptoms persist see your healthcare professional.
Visual appearance
White, round, film-coated tablet debossed with 'Pfizer' on one side and 'JKI 5' on the other side.
Images are the copyright of the Pharmacy Guild of Australia
Do I need a prescription?
This medicine is available from a pharmacist and requires a prescription. It is
Schedule 4 : Prescription Only Medicine.
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
This medicine is under additional monitoring as it is new or being used in a different way. You can help identify new safety information by reporting any side effects you may get.
Ulcerative Colitis: XELJANZ is indicated for the treatment of adult patients with moderately to severely active
ulcerative colitis (UC) who have had an inadequate response, lost response, or were intolerant
to either conventional therapy or a biological therapy.,Psoriatic Arthritis: XELJANZ in combination with conventional synthetic DMARDs is indicated for the
treatment of active psoriatic arthritis in adult patients who have had an inadequate response to
a prior DMARD therapy.,Ulcerative Colitis: XELJANZ is indicated for the treatment of adult patients with moderately to severely active ulcerative colitis (UC) who have had an inadequate response, lost response, or were intolerant to either conventional therapy or a biological therapy.
How to take it
The way to take this medicine is: Oral.
This medicine is taken by mouth.
Store below 30 degrees Celsius
Shelf lifetime is 3 Years.
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.
Always read the label. If symptoms persist see your healthcare professional.
Visual appearance
10 mg film-coated immediate release tablet: blue, film-coated, round tablet debossed with Pfizer on one side and JKI10 on the other side
Images are the copyright of the Pharmacy Guild of Australia
Do I need a prescription?
This medicine is available from a pharmacist and requires a prescription. It is
Schedule 4 : Prescription Only Medicine.
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
This medicine is under additional monitoring as it is new or being used in a different way. You can help identify new safety information by reporting any side effects you may get.
Ulcerative Colitis: XELJANZ is indicated for the treatment of adult patients with moderately to severely active
ulcerative colitis (UC) who have had an inadequate response, lost response, or were intolerant
to either conventional therapy or a biological therapy.,Psoriatic Arthritis: XELJANZ in combination with conventional synthetic DMARDs is indicated for the
treatment of active psoriatic arthritis in adult patients who have had an inadequate response to
a prior DMARD therapy.,Ulcerative Colitis: XELJANZ is indicated for the treatment of adult patients with moderately to severely active ulcerative colitis (UC) who have had an inadequate response, lost response, or were intolerant to either conventional therapy or a biological therapy.
How to take it
The way to take this medicine is: Oral.
This medicine is taken by mouth.
Store below 30 degrees Celsius
Shelf lifetime is 3 Years.
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.
Always read the label. If symptoms persist see your healthcare professional.
Visual appearance
10 mg film-coated immediate release tablet: blue, film-coated, round tablet debossed with Pfizer on one side and JKI10 on the other side
Images are the copyright of the Pharmacy Guild of Australia
Do I need a prescription?
This medicine is available from a pharmacist and requires a prescription. It is
Schedule 4 : Prescription Only Medicine.
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
This medicine is under additional monitoring as it is new or being used in a different way. You can help identify new safety information by reporting any side effects you may get.
Rheumatoid Arthritis:,XELJANZ is indicated for the treatment of moderate to severe active rheumatoid arthritis in
adults who have had an inadequate response or are intolerant to methotrexate. XELJANZ
can be used alone or in combination with conventional synthetic disease-modifying
antirheumatic drugs (DMARDs), including methotrexate.,Psoriatic Arthritis: XELJANZ in combination with conventional synthetic DMARDs is indicated for the
treatment of active psoriatic arthritis in adult patients who have had an inadequate response to
a prior DMARD therapy.,Ulcerative Colitis: XELJANZ is indicated for the treatment of adult patients with moderately to severely active ulcerative colitis (UC) who have had an inadequate response, lost response, or were intolerant to either conventional therapy or a biological therapy.,Psoriatic Arthritis:
XELJANZ in combination with conventional synthetic DMARDs is indicated for the
treatment of active psoriatic arthritis in adult patients who have had an inadequate response to
a prior DMARD therapy.,Ulcerative Colitis:
XELJANZ is indicated for the treatment of adult patients with moderately to severely active ulcerative colitis (UC) who have had an inadequate response, lost response, or were intolerant to either conventional therapy or a biological therapy.
How to take it
The way to take this medicine is: Oral.
This medicine is taken by mouth.
Store below 30 degrees Celsius
Shelf lifetime is 3 Years.
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.
Always read the label. If symptoms persist see your healthcare professional.
Visual appearance
White, round, film-coated tablet debossed with 'Pfizer' on one side and 'JKI 5' on the other side.
Images are the copyright of the Pharmacy Guild of Australia
Do I need a prescription?
This medicine is available from a pharmacist and requires a prescription. It is
Schedule 4 : Prescription Only Medicine.
Is this medicine subsidised?
This medicine was verified as being available on the PBS (Pharmaceutical Benefits Scheme) on April 1, 2021. To learn more about this subsidy, visit the Pharmaceutical Benefits Scheme (PBS) website.
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
This medicine is under additional monitoring as it is new or being used in a different way. You can help identify new safety information by reporting any side effects you may get.
